GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CTC Bio Inc (XKRX:060590) » Definitions » Ending Cash Position

CTC Bio (XKRX:060590) Ending Cash Position : ₩21,294 Mil (As of Mar. 2024)


View and export this data going back to 2002. Start your Free Trial

What is CTC Bio Ending Cash Position?

CTC Bio's Ending Cash Position for the quarter that ended in Mar. 2024 was ₩21,294 Mil.

CTC Bio's quarterly Ending Cash Position declined from Sep. 2023 (₩26,761 Mil) to Dec. 2023 (₩24,629 Mil) and declined from Dec. 2023 (₩24,629 Mil) to Mar. 2024 (₩21,294 Mil).

CTC Bio's annual Ending Cash Position increased from Dec. 2021 (₩7,415 Mil) to Dec. 2022 (₩23,953 Mil) and increased from Dec. 2022 (₩23,953 Mil) to Dec. 2023 (₩24,629 Mil).

CTC Bio Ending Cash Position Historical Data

The historical data trend for CTC Bio's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CTC Bio Ending Cash Position Chart

CTC Bio Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15,269.96 12,173.72 7,415.04 23,953.04 24,629.02

CTC Bio Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24,545.93 27,665.91 26,761.47 24,629.02 21,293.61

CTC Bio Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

CTC Bio's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=23953.038+675.979
=24,629

CTC Bio's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=24629.017+-3335.403
=21,294

CTC Bio Ending Cash Position Related Terms

Thank you for viewing the detailed overview of CTC Bio's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

CTC Bio (XKRX:060590) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CTC Bio Inc (XKRX:060590) » Definitions » Ending Cash Position
Comparable Companies
XKRX:011000 XKRX:053030 XKRX:048870 XKRX:397030 XKRX:115450 XKRX:083790 XKRX:048530 XKRX:086890 XKRX:199800 XKRX:278650 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
94, Saengmyeonggwahakgwan-gil, Gangwon-do, Hongcheon, KOR, 25142
Website
http://www.ctcbio.com
CTC Bio Inc is engaged in the manufacturing and distribution of pharmaceutical products, veterinary medicines, feed additives, feed ingredients, and functional foods.

CTC Bio (XKRX:060590) Headlines

No Headlines